The EBITDA margin stood at 12.6% in the reporting quarter versus 13.7% in the same period last fiscal. Shares of Rossari Biotech Ltd ended at ₹800.95, down by ₹18.90, or 2.31%, on the BSE.
The EBITDA margin stood at 12.6% in the reporting quarter versus 13.7% in the same period last fiscal. Shares of Rossari Biotech Ltd ended at ₹800.95, down by ₹18.90, or 2.31%, on the BSE.